The Showa disk susceptibility test (Showa Yakuhin Kako Company, Japan) was evaluated to discriminate between the strains of Staphylococcus aureus resistant to penicillinase-resistant penicillins (PRPs) and those susceptible. When we tested 129 PRP-resistant and 112 susceptible strains, many PRP-resistant strains were interpreted to be false susceptible to methicillin and oxacillin, especially when incubated at 37-degrees-C. Growth at 30-degrees-C and when NaCl was added to the medium improved the test reliability for detection of PRP resistance. Ceftizoxime disk (30-mu-g) susceptibility test results highly correlated with reference PRP resistance when incubated at 35-degrees-C. All the PRP-resistant strains produced no zone of inhibition, whereas all of the PRP-susceptible strains were categorized as susceptible to ceftizoxime (greater-than-or-equal-to 22 mm, less-than-or-equal-to 3.13-mu-g/ml), for example, 100% correlation. It was concluded that the Showa ceftizoxime disk, in replacement of PRPs, will provide a reliable, alternative method to predict PRP resistance in S. aureus pending reevaluation of the Show PRP disk tests.